Dhiti Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.98 Cr
- Satisfied Charges ₹ 3.15 Cr
- Revenue Growth 70.23%
- Profit Growth 979.42%
- Ebitda 190.97%
- Net Worth 76.20%
- Total Assets 48.74%
About Dhiti Biotech (India)
Dhiti Biotech (India) Private Limited (DBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 February 2002 and has a history of 22 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹10.98 Cr. The company has closed loans amounting to ₹3.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Savita Sekhri, Anand Sekhri, and Naresh Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231DL2002PTC114385
-
Company No.
114385
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Feb 2002
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dhiti Biotech (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita Sekhri
|
Director | 26-Feb-2002 | Current |
|
Anand Sekhri
|
Director | 25-Aug-2006 | Current |
|
Naresh Singh
|
Director | 11-Sep-2023 | Current |
Financial Performance of Dhiti Biotech (India).
Dhiti Biotech (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 70.23% increase. The company also saw a substantial improvement in profitability, with a 979.42% increase in profit. The company's net worth Soared by an impressive increase of 76.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhiti Biotech (India)?
In 2022, Dhiti Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
O2 Pathlabs Private LimitedAnand Sekhri and Naresh Singh are mutual person
-
Dhiti Life Sciences Private LimitedSavita Sekhri and Naresh Singh are mutual person
-
Oscar Medicare Private LimitedSavita Sekhri and Naresh Singh are mutual person
-
Dr. Sekhri Diagnostics LlpSavita Sekhri is a mutual person
-
Dhiti Biologicals Private Limited
Savita Sekhri and Naresh Singh are mutual person
-
Dhiti Biomedical Devices Private Limited
Savita Sekhri and Naresh Singh are mutual person
Charges (Loans)
₹109.76 M
₹31.46 M
Charges Breakdown by Lending Institutions
- Others : 9.92 Cr
- Indian Overseas Bank : 0.99 Cr
- Corporation Bank : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2020 | Others | ₹8.40 M | Open |
| 21 Nov 2020 | Others | ₹4.50 Cr | Open |
| 26 Jun 2020 | Indian Overseas Bank | ₹8.40 M | Open |
| 10 Jan 2017 | Others | ₹0.76 M | Open |
| 10 May 2007 | Others | ₹4.50 Cr | Open |
How Many Employees Work at Dhiti Biotech (India)?
Unlock and access historical data on people associated with Dhiti Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhiti Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhiti Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
